S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
S&P 500   2,526.90 (+2.28%)
DOW   21,413.44 (+2.24%)
QQQ   186.01 (+2.03%)
AAPL   244.93 (+1.67%)
FB   158.19 (-0.88%)
MSFT   155.26 (+2.07%)
GOOGL   1,117.03 (+1.35%)
AMZN   1,918.83 (+0.58%)
CGC   13.80 (+1.62%)
NVDA   255.47 (+5.10%)
BABA   188.90 (+0.71%)
MU   41.09 (+3.01%)
GE   6.90 (-1.99%)
TSLA   454.47 (-5.63%)
AMD   44.49 (+1.90%)
T   28.76 (+2.53%)
ACB   0.83 (+2.46%)
F   4.36 (-0.91%)
NFLX   370.08 (+1.65%)
BAC   20.57 (+4.05%)
GILD   76.98 (+6.16%)
PRI   82.76 (-1.66%)
DIS   96.97 (+2.16%)
Log in

LON:OBD - Oxford Biodynamics Share Price, Forecast & News

GBX 56
-0.25 (-0.44 %)
(As of 04/2/2020 04:00 PM ET)
Today's Range
55
Now: GBX 56
56.19
50-Day Range
51
MA: GBX 75.67
97
52-Week Range
47
Now: GBX 56
170
Volume66,115 shs
Average Volume67,675 shs
Market Capitalization£51.83 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures. It has collaboration agreements with Holos Life Sciences Pte. Ltd. to develop non-invasive epigenetic biomarkers associated with sports-related concussions; and Casa Sollievo della Sofferenza to identify EpiSwitch biomarkers for the blood-based diagnosis of Autism Spectrum Disorder. The company was founded in 2007 and is headquartered in Oxford, the United Kingdom.
Read More

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1865-518910

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£907,000.00
Cash FlowGBX 16.41 per share
Book ValueGBX 19 per share

Profitability

Miscellaneous

Employees31
Market Cap£51.83 million
Next Earnings DateN/A
OptionableNot Optionable

Receive OBD News and Ratings via Email

Sign-up to receive the latest news and ratings for OBD and its competitors with MarketBeat's FREE daily newsletter.


Oxford Biodynamics (LON:OBD) Frequently Asked Questions

How has Oxford Biodynamics' stock been impacted by COVID-19 (Coronavirus)?

Oxford Biodynamics' stock was trading at GBX 77.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OBD shares have decreased by 27.7% and is now trading at GBX 56. View which stocks have been mosted impacted by Coronavirus.

How were Oxford Biodynamics' earnings last quarter?

Oxford Biodynamics PLC (LON:OBD) issued its quarterly earnings data on Tuesday, December, 10th. The biotechnology company reported ($3.00) earnings per share (EPS) for the quarter. View Oxford Biodynamics' earnings history.

Has Oxford Biodynamics been receiving favorable news coverage?

Media headlines about OBD stock have trended very negative recently, InfoTrie Sentiment reports. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Oxford Biodynamics earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutOxford Biodynamics.

Who are some of Oxford Biodynamics' key competitors?

What other stocks do shareholders of Oxford Biodynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford Biodynamics investors own include Oxford BioMedica (OXB), GALAPAGOS NV/S (GLPG), Fate Therapeutics (FATE), Casey's General Stores (CASY), AXT (AXTI), American Woodmark (AMWD), Savannah Resources (SAV), Nanoco Group (NANO), Biffa (BIFF) and Valdor Technology International (VTI).

Who are Oxford Biodynamics' key executives?

Oxford Biodynamics' management team includes the following people:
  • Mr. Christian Gurth Hoyer Millar, CEO & Director (Age 60)
  • Mr. Paul Leslie Stockdale, CFO & Director (Age 44)
  • Dr. Alexandre Akoulitchev, Chief Scientific Officer & Director (Age 57)
  • Mr. Glen A. Ferguson, Pres & Sr. VP of Group's Bus. Devel. of USA
  • Dr. Aroul Ramadass Ph.D.(CANTAB), PDF (OXON), FCPS, FRAS, Chief Technology Officer

What is Oxford Biodynamics' stock symbol?

Oxford Biodynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."

How do I buy shares of Oxford Biodynamics?

Shares of OBD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford Biodynamics' stock price today?

One share of OBD stock can currently be purchased for approximately GBX 56.

How big of a company is Oxford Biodynamics?

Oxford Biodynamics has a market capitalization of £51.83 million and generates £907,000.00 in revenue each year. Oxford Biodynamics employs 31 workers across the globe. View additional information about Oxford Biodynamics.

What is Oxford Biodynamics' official website?

The official website for Oxford Biodynamics is http://www.oxfordbiodynamics.com/.

How can I contact Oxford Biodynamics?

Oxford Biodynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The biotechnology company can be reached via phone at +44-1865-518910.


MarketBeat Community Rating for Oxford Biodynamics (LON OBD)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  211
MarketBeat's community ratings are surveys of what our community members think about Oxford Biodynamics and other stocks. Vote "Outperform" if you believe OBD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OBD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/2/2020 by MarketBeat.com Staff

Featured Article: Blockchain

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel